Global Health Limited has come up with an initial public offer (IPO). It will open on November 03-07, 2022 at Rs.319-336 a share. The IPO issue size is around Rs.2,205.57 crore. The minimum bid will be for 44 shares and in its multiples thereafter.
Overview
Global Health is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues. It operates in the North and East regions of India. It has key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.
Under the “Medanta” brand, the company has a network of five hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction. It provides healthcare services in over 30 medical specialties and engage over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft. & operational hospitals have 2,467 installed beds.
In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, company has generated income from healthcare services of Rs.14,805.71 million, Rs.14,178.41 million, Rs.21,003.95 million, Rs.4,732.10 million and Rs.5,960.89 381 million, respectively, and had EBITDA of Rs.2,304.54 million, Rs.2,228.52 million, Rs.4,897.57 million, Rs.1,057.69 million and Rs.1,416.46 million, respectively.
Website – https://www.medanta.org/
Promoters
Dr. Naresh Trehan – 35% |
Promoter Holding
Pre-Issue Shareholding – 35.00% | Post-Issue Shareholding – 33.00% |
Strength & Weakness
Strengths | Weaknesses |
Focus on Clinical Research and Academics | Highly dependent on doctors & nurses |
Driven by skilled and experienced doctors | Healthcare services has high costs |
Large-scale hospitals with sophisticated infrastructure, equipment and technology | Doesn’t have sufficient insurance coverage |
Track record of operational and financial performance | Subject to medical and legal risks |
Focus on under-served areas with dense population | Rely on third-party suppliers and sub-contractors |
Presence in top or capital cities of large states | Depend on financing from the banks or FIs to carry on business operations |
Experienced senior management team | Increased competition from other hospitals |
Diversification into new services | Outstanding litigation against Directors |
Competitors
Apollo Hospitals | Fortis Healthcare |
Max Healthcare | Narayana Hrudayalaya |
Company Financials
Year | Revenue (in Crore) | Profit (in Crore) |
31-Mar-2020 | 1,544.26 | 36.32 |
31-Mar-2021 | 1,478.15 | 28.80 |
31-Mar-2022 | 2,205.82 | 196.20 |
30-Jun-2022 | 626.54 | 58.71 |
Object of Issue
1) The Offer for Sale of Equity Shares by the Selling Shareholders
2) For repayment/prepayment of borrowings, in full or part, of Subsidiaries – GHPPL and MHPL
3) General corporate purposes
Global Health IPO Lot Size
Application | Lot | Shares | Amount |
Retail (Min) | 1 | 44 | Rs.14,784 |
Retail (Max) | 13 | 572 | Rs.1,92,192 |
S-HNI (Min) | 14 | 616 | Rs.2,06,976 |
B-HNI (Max) | 68 | 2,992 | Rs.10,05,312 |
Global Health IPO Details
IPO Opening Date | November 03, 2022 |
IPO Closing Date | November 07, 2022 |
Face Value | Rs.2 per Equity Share |
IPO Price | Rs.319-336 per share |
Market Lot | 44 shares |
Minimum Order Quantity | 44 shares |
Listing At | NSE, BSE |
No. of shares offered (OFS) | 5,07,61,000 shares |
Issue Size | Up to Rs.2,205.57 Crore |
QIB Shares Offered | 50% of the offer |
Retail Shares Offered | 35% of the offer |
NII/HNI Shares Offered | 15% of the offer |
Global Health IPO Timetable
IPO Date | November 03-07, 2022 |
Allotment Date | November 11, 2022 |
Initiation of Refunds | November 14, 2022 |
Credit of share to Demat a/c | November 15, 2022 |
IPO Listing Date | November 16, 2022 |
Allotment Status
KFintech Technologies – https://ris.kfintech.com/ipostatus/
Book Lead Managers
Registrar